2 months ago
VKTX
AnalystsJustin ZelinJustin Zelin's Stock Forecasts
AnalystsJustin Zelin
Sectors:
Industries:
Analyst Ranking
Top 22%
#1001 out of 4595 analysts
Average Return
+16.92%
Win Rate
27%9 out of 33
Risk vs Reward
Poor
Good
Justin Zelin's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
89bio IncETNB | +437.68% | $3.45 | $18.55 | 2022-06-29 - 2023-06-28 | Strong Buy |
Viking Therapeutics IncVKTX | +414.75% | $15.93 | $82.00 | 2023-03-29 - 2024-03-28 | Strong Buy |
Bellus Health IncBLU | +241.96% | $2.86 | $9.78 | 2021-07-29 - 2022-07-28 | Strong Buy |
Viking Therapeutics IncVKTX | +216.53% | $24.65 | $78.01 | 2023-05-16 - 2024-05-15 | Strong Buy |
Casi Pharmaceuticals IncCASI | +130.16% | $1.89 | $4.35 | 2022-11-16 - 2023-11-15 | Strong Buy |
Justin Zelin Analyst Color
Get additional color on Justin Zelin's coverage of popular stocks
3 months ago
VKTX
10 months ago
IMCR
a year ago
ETNB
a year ago
SNDX
a year ago
MBIO
a year ago
LEGN
a year ago
GRCL
a year ago
LEGN
a year ago
VKTX
Justin Zelin's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Tscan Therapeutics IncTCRX | 1 | Strong Buy | $12.00 | +40.35% | Initiates Coverage On | 18 days ago |
Carisma Therapeutics IncCARM | 1 | Strong Buy | $6.00 | +351.13% | Initiates Coverage On | 2 months ago |
Viking Therapeutics IncVKTX | 4 | Strong Buy | $125.00 | +100.77% | Maintains | 2 months ago |
Ideaya Biosciences IncIDYA | 1 | Strong Buy | $55.00 | +50.48% | Initiates Coverage On | 3 months ago |
Verastem IncVSTM | 1 | Strong Buy | $27.00 | +581.82% | Assumes | 6 months ago |
Lyra Therapeutics IncLYRA | 1 | Strong Buy | $15.00 | +4,473.17% | Assumes | 8 months ago |
Mustang Bio IncMBIO | 4 | Strong Buy | $16.00 | +7,860.20% | Maintains | 10 months ago |
Immunocore Holdings PLCIMCR | 2 | Strong Buy | $91.00 | +85.79% | Maintains | 10 months ago |
Adicet Bio IncACET | 2 | Strong Buy | $10.00 | +589.66% | Maintains | 10 months ago |
Prokidney CorpPROK | 1 | Strong Buy | $16.00 | +359.77% | Initiates Coverage On | 10 months ago |
89bio IncETNB | 2 | Strong Buy | $37.00 | +368.35% | Maintains | a year ago |
Syndax Pharmaceuticals IncSNDX | 1 | Strong Buy | $35.00 | +81.63% | Maintains | a year ago |
Legend Biotech CorpLEGN | 2 | Strong Buy | $90.00 | +124.94% | Maintains | a year ago |
Gracell Biotechnologies IncGRCL | 2 | Strong Buy | $20.00 | +95.12% | Maintains | a year ago |
Kura Oncology IncKURA | 1 | Strong Buy | $31.00 | N/A | Initiates Coverage On | a year ago |
Novo Nordisk A SNVO | 1 | Strong Buy | $15.50 | N/A | Maintains | a year ago |
Mei Pharma IncMEIP | 2 | Hold | N/A | N/A | Downgrades | a year ago |
Casi Pharmaceuticals IncCASI | 2 | Strong Buy | $10.00 | N/A | Maintains | 2 years ago |
Bellus Health IncBLU | 1 | Strong Buy | $9.00 | N/A | Initiates Coverage On | 3 years ago |
Surface Oncology IncSURF | 1 | Strong Buy | $17.00 | N/A | Initiates Coverage On | 3 years ago |
Poseida Therapeutics IncPSTX | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.